Terug
Dagbereik
€ 18,77
€ 19,90
52-Weeksbereik
€ 6,78
€ 23,56
Volume
1.603.050
50D / 200D Gem.
€ 20,09
/
€ 15,36
Vorige Slotkoers
€ 19,14
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -58,1 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | -5,8 | 3,7 |
| Net Margin % | -6,8 | 3,9 |
| Rev Growth 5Y % | 7,0 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 21,00
+6.0%
Low: € 17,00
High: € 25,00
Forward WPA
-€ 0,84
Omzet Sch.
610 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,36
-€ 0,37 – -€ 0,35
|
840 M | 4 |
| FY2029 |
-€ 0,37
-€ 0,38 – -€ 0,36
|
780 M | 4 |
| FY2028 |
-€ 0,53
-€ 0,85 – -€ 0,07
|
710 M | 11 |
Belangrijkste Punten
Revenue grew 7,00% annually over 5 years — modest growth
Debt/Equity of 0,20 — conservative balance sheet
Generating 130,12M in free cash flow
PEG of 0,61 suggests growth is underpriced
Capital efficient — spends only 0,92% of revenue on capex
Groei
Revenue Growth (5Y)
7,00%
Revenue (1Y)5,25%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-5,78%
ROIC-8,72%
Net Margin-6,77%
Op. Margin-17,25%
Veiligheid
Debt / Equity
0,20
Current Ratio4,46
Interest Coverage0,00
Waardering
P/E Ratio
-58,12
P/B Ratio3,18
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,25% | Revenue Growth (3Y) | 1,93% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7,00% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 642,82M | Net Income (TTM) | -43,54M |
| ROE | -5,78% | ROA | -4,18% |
| Gross Margin | 69,05% | Operating Margin | -17,25% |
| Net Margin | -6,77% | Free Cash Flow (TTM) | 130,12M |
| ROIC | -8,72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,20 | Current Ratio | 4,46 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -58,12 | P/B Ratio | 3,18 |
| P/S Ratio | 3,94 | PEG Ratio | 0,61 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,53B | Enterprise Value | 2,21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 642,82M | 610,79M | 618,73M | 516,41M | 490,49M |
| Net Income | -43,54M | -182,63M | -255,10M | -166,00M | -58,22M |
| EPS (Diluted) | -0,35 | -1,52 | -2,18 | -1,46 | -0,53 |
| Gross Profit | 443,88M | 414,48M | 409,31M | 396,02M | 416,40M |
| Operating Income | -110,89M | -194,56M | -265,33M | -167,94M | -52,91M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,04B | 918,64M | 965,14M | 1,03B | 1,02B |
| Total Liabilities | 245,04M | 208,50M | 224,10M | 223,24M | 201,26M |
| Shareholders' Equity | 796,33M | 710,13M | 741,04M | 805,74M | 817,57M |
| Total Debt | 157,74M | 82,61M | 95,37M | 95,18M | 81,98M |
| Cash & Equivalents | 473,97M | 344,07M | 359,28M | 219,75M | 587,45M |
| Current Assets | 684,45M | 584,39M | 596,02M | 635,04M | 747,59M |
| Current Liabilities | 153,45M | 117,63M | 127,16M | 130,96M | 110,36M |